• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿酸水平与慢性肾脏病相关性的系统评价和荟萃分析。

A systematic review and meta-analysis of the association between uric acid levels and chronic kidney disease.

机构信息

School of Medicine, Federal University of Uberlândia, Uberlândia, Minas Gerais, Brazil.

Department of Medicine and Nursing, Federal University of Viçosa, Viçosa, Minas Gerais, Brazil.

出版信息

Sci Rep. 2022 Apr 15;12(1):6251. doi: 10.1038/s41598-022-10118-x.

DOI:10.1038/s41598-022-10118-x
PMID:35428828
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9012819/
Abstract

The function of uric acid (UA) in the genesis and evolution of chronic kidney disease (CKD) has motivated numerous studies, but the results remain inconclusive. We sought to conduct a systematic review and meta-analysis of cohort studies aiming to analyze the association of UA levels with the incidence and progression of CKD. Pubmed/Medline, Lilacs/Bireme and Web of Science were searched to identify eligible studies, following the PRISMA protocol. Data were presented for CKD incidence and progression separately. For the meta-analysis, studies with data stratified by subgroups according to serum UA levels were selected. The inverse variance-weighted random effects model was used to generate a combined effect estimate. Meta-regressions were performed to identify the causes of heterogeneity. The Newcastle-Ottawa Scale was used to assess the risk of bias. The publication bias was tested by funnel plot and Egger's test. Eighteen CKD incidence studies (n = 398,663) and six CKD progression studies (n = 13,575) were included. An inverse relationship was observed between UA levels and protection from CKD incidence and progression. Lower UA levels were protective for the risk of CKD incidence (RR 0.65 [95% CI 0.56-0.75]) and progression (RR 0.55 [95% CI 0.44-0.68]). UA seems to be implicated both in the genesis of CKD and its evolution.

摘要

尿酸(UA)在慢性肾脏病(CKD)发生和进展中的作用激发了众多研究,但结果仍不确定。我们旨在对队列研究进行系统回顾和荟萃分析,以分析 UA 水平与 CKD 发病率和进展的相关性。根据 PRISMA 协议,检索了 Pubmed/Medline、Lilacs/Bireme 和 Web of Science 以确定合格的研究。分别呈现 CKD 发病率和进展的数据。对于荟萃分析,选择了根据血清 UA 水平分层数据的研究。采用逆方差加权随机效应模型生成综合效应估计值。进行荟萃回归以确定异质性的原因。使用纽卡斯尔-渥太华量表评估偏倚风险。通过漏斗图和 Egger 检验测试发表偏倚。纳入了 18 项 CKD 发病率研究(n=398663)和 6 项 CKD 进展研究(n=13575)。UA 水平与 CKD 发病率和进展的保护作用呈负相关。较低的 UA 水平可降低 CKD 发病率(RR 0.65 [95% CI 0.56-0.75])和进展(RR 0.55 [95% CI 0.44-0.68])的风险。UA 似乎既参与 CKD 的发生,也参与其进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac22/9012819/0dd1fcb9042f/41598_2022_10118_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac22/9012819/9defa6536fe7/41598_2022_10118_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac22/9012819/feadaa866cce/41598_2022_10118_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac22/9012819/b508319dfdbb/41598_2022_10118_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac22/9012819/0dd1fcb9042f/41598_2022_10118_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac22/9012819/9defa6536fe7/41598_2022_10118_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac22/9012819/feadaa866cce/41598_2022_10118_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac22/9012819/b508319dfdbb/41598_2022_10118_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac22/9012819/0dd1fcb9042f/41598_2022_10118_Fig4_HTML.jpg

相似文献

1
A systematic review and meta-analysis of the association between uric acid levels and chronic kidney disease.尿酸水平与慢性肾脏病相关性的系统评价和荟萃分析。
Sci Rep. 2022 Apr 15;12(1):6251. doi: 10.1038/s41598-022-10118-x.
2
Serum uric acid and the incidence of CKD and hypertension.血清尿酸与慢性肾脏病及高血压的发病率
Clin Exp Nephrol. 2015 Dec;19(6):1127-34. doi: 10.1007/s10157-015-1120-4. Epub 2015 May 13.
3
Serum uric acid is associated with incident chronic kidney disease in middle-aged populations: a meta-analysis of 15 cohort studies.血清尿酸与中年人群慢性肾脏病的发生相关:15项队列研究的荟萃分析
PLoS One. 2014 Jun 24;9(6):e100801. doi: 10.1371/journal.pone.0100801. eCollection 2014.
4
Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: A systematic review and meta-analysis.非酒精性脂肪性肝病增加了慢性肾脏病发病的风险:系统评价和荟萃分析。
Metabolism. 2018 Feb;79:64-76. doi: 10.1016/j.metabol.2017.11.003. Epub 2017 Nov 11.
5
Uric acid and incident chronic kidney disease in a large health check-up population in Taiwan.尿酸与台湾地区大型体检人群中慢性肾脏病的发病关系。
Nephrology (Carlton). 2011 Nov;16(8):767-76. doi: 10.1111/j.1440-1797.2011.01513.x.
6
High uric acid level is a risk factor for progression of IgA nephropathy with chronic kidney disease stage G3a.高尿酸水平是IgA肾病伴慢性肾脏病G3a期进展的一个危险因素。
J Nephrol. 2015 Aug;28(4):451-6. doi: 10.1007/s40620-014-0154-0. Epub 2014 Oct 30.
7
Effects of uric acid-lowering therapy on the progression of chronic kidney disease: a systematic review and meta-analysis.降低尿酸治疗对慢性肾脏病进展的影响:系统评价和荟萃分析。
Ren Fail. 2018 Nov;40(1):289-297. doi: 10.1080/0886022X.2018.1456463.
8
Uric acid and incident chronic kidney disease in dyslipidemic individuals.尿酸与血脂异常个体中的慢性肾脏病事件。
Curr Med Res Opin. 2018 Jul;34(7):1193-1199. doi: 10.1080/03007995.2017.1372157. Epub 2017 Sep 21.
9
Dietary Approaches to Stop Hypertension and risk of chronic kidney disease: A systematic review and meta-analysis of observational studies.膳食干预防治高血压与慢性肾病风险:观察性研究的系统评价和荟萃分析。
Clin Nutr. 2020 Jul;39(7):2035-2044. doi: 10.1016/j.clnu.2019.10.004. Epub 2019 Oct 15.
10
Serum uric acid levels in patients with Parkinson's disease: A meta-analysis.帕金森病患者的血清尿酸水平:一项荟萃分析。
PLoS One. 2017 Mar 20;12(3):e0173731. doi: 10.1371/journal.pone.0173731. eCollection 2017.

引用本文的文献

1
Elevated Pulse Pressure and Risk of Chronic Kidney Disease by Hypertension Status: A Longitudinal Study in Japanese Adults.高血压状态下脉压升高与慢性肾脏病风险:一项针对日本成年人的纵向研究
High Blood Press Cardiovasc Prev. 2025 Sep 16. doi: 10.1007/s40292-025-00735-8.
2
Investigation of Pharmacological Mechanisms and Active Ingredients of L. in Alleviating Renal Urate Deposition via lncRNA H19/miR-21-3p Regulation to Enhance ABCG2 Expression.通过lncRNA H19/miR-21-3p调控增强ABCG2表达来探究L.减轻肾尿酸沉积的药理机制及活性成分
Int J Mol Sci. 2025 Aug 15;26(16):7892. doi: 10.3390/ijms26167892.
3
The impact of serum uric acid on biological aging and mortality risk: insights from the NHANES and CHARLS cohorts.

本文引用的文献

1
Relationship between sex and cardiovascular mortality in chronic kidney disease: A systematic review and meta-analysis.慢性肾脏病患者心血管死亡率的性别差异:系统评价和荟萃分析。
PLoS One. 2021 Jul 12;16(7):e0254554. doi: 10.1371/journal.pone.0254554. eCollection 2021.
2
Association of uric acid with kidney function and albuminuria: the Uric Acid Right for heArt Health (URRAH) Project.尿酸与肾功能和蛋白尿的关系:心脏健康尿酸合适水平研究(URRAH)项目。
J Nephrol. 2022 Jan;35(1):211-221. doi: 10.1007/s40620-021-00985-4. Epub 2021 Mar 23.
3
The effect of baseline serum uric acid on chronic kidney disease in normotensive, normoglycemic, and non-obese individuals: A health checkup cohort study.
血清尿酸对生物衰老和死亡风险的影响:来自美国国家健康与营养检查调查(NHANES)和中国健康与养老追踪调查(CHARLS)队列的见解
Front Nutr. 2025 Apr 22;12:1569798. doi: 10.3389/fnut.2025.1569798. eCollection 2025.
4
The Perception of Illness in People with Advanced Chronic Kidney Disease.晚期慢性肾病患者对疾病的认知
J Pers Med. 2025 Mar 20;15(3):120. doi: 10.3390/jpm15030120.
5
Hyperuricemia-induced complications: dysfunctional macrophages serve as a potential bridge.高尿酸血症引发的并发症:功能失调的巨噬细胞充当潜在桥梁。
Front Immunol. 2025 Jan 28;16:1512093. doi: 10.3389/fimmu.2025.1512093. eCollection 2025.
6
Association of serum uromodulin with diabetic kidney disease: a systematic review and meta-analysis.血清尿调蛋白与糖尿病肾病的关系:系统评价和荟萃分析。
BMC Nephrol. 2024 Nov 24;25(1):421. doi: 10.1186/s12882-024-03854-x.
7
Advanced Gouty Nephropathy Complicated With Type 1 Renal Tubular Acidosis: A Case Report.晚期痛风性肾病合并1型肾小管酸中毒:一例报告
Cureus. 2024 Oct 8;16(10):e71094. doi: 10.7759/cureus.71094. eCollection 2024 Oct.
8
Interplay between the Redox System and Renal Tubular Transport.氧化还原系统与肾小管转运之间的相互作用。
Antioxidants (Basel). 2024 Sep 24;13(10):1156. doi: 10.3390/antiox13101156.
9
Effects of allopurinol and febuxostat on uric acid transport and transporter expression in human umbilical vein endothelial cells.别嘌醇和非布司他对人脐静脉内皮细胞尿酸转运及转运体表达的影响。
PLoS One. 2024 Jun 21;19(6):e0305906. doi: 10.1371/journal.pone.0305906. eCollection 2024.
10
Effect of uric acid reduction on chronic kidney disease. Systematic review and meta-analysis.降低尿酸对慢性肾脏病的影响。系统评价与荟萃分析。
Front Pharmacol. 2024 Mar 26;15:1373258. doi: 10.3389/fphar.2024.1373258. eCollection 2024.
在血压正常、血糖正常且非肥胖的个体中,基线血清尿酸对慢性肾脏病的影响:一项健康体检队列研究。
PLoS One. 2021 Jan 27;16(1):e0244106. doi: 10.1371/journal.pone.0244106. eCollection 2021.
4
Effects of Allopurinol on the Progression of Chronic Kidney Disease.别嘌醇对慢性肾脏病进展的影响。
N Engl J Med. 2020 Jun 25;382(26):2504-2513. doi: 10.1056/NEJMoa1915833.
5
Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 Diabetes.别嘌醇降低血清尿酸与 1 型糖尿病患者的肾功能。
N Engl J Med. 2020 Jun 25;382(26):2493-2503. doi: 10.1056/NEJMoa1916624.
6
Oxidative Stress in the Pathophysiology of Kidney Disease: Implications for Noninvasive Monitoring and Identification of Biomarkers.氧化应激在肾脏疾病发病机制中的作用:对非侵入性监测和生物标志物识别的影响。
Oxid Med Cell Longev. 2020 Jan 23;2020:5478708. doi: 10.1155/2020/5478708. eCollection 2020.
7
Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、区域和国家慢性肾脏病负担,1990-2017 年:2017 年全球疾病负担研究的系统分析。
Lancet. 2020 Feb 29;395(10225):709-733. doi: 10.1016/S0140-6736(20)30045-3. Epub 2020 Feb 13.
8
Asymptomatic hyperuricaemia: a silent activator of the innate immune system.无症状高尿酸血症:固有免疫系统的沉默激活剂。
Nat Rev Rheumatol. 2020 Feb;16(2):75-86. doi: 10.1038/s41584-019-0334-3. Epub 2019 Dec 10.
9
Asymptomatic hyperuricemia: is it really asymptomatic?无症状高尿酸血症:真的无症状吗?
Curr Opin Rheumatol. 2020 Jan;32(1):71-79. doi: 10.1097/BOR.0000000000000679.
10
Multifactorial functions of the inflammasome component NLRP3 in pathogenesis of chronic kidney diseases.炎症小体组分 NLRP3 在慢性肾脏病发病机制中的多效性功能。
Kidney Int. 2019 Jul;96(1):58-66. doi: 10.1016/j.kint.2019.01.014. Epub 2019 Mar 4.